StimCell Enegetics Inc
OTC:STME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
StimCell Enegetics Inc
Net Issuance of Debt
StimCell Enegetics Inc
Net Issuance of Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
StimCell Enegetics Inc
OTC:STME
|
Net Issuance of Debt
$112.9k
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
|
|
Profound Medical Corp
TSX:PRN
|
Net Issuance of Debt
-$290k
|
CAGR 3-Years
7%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Net Issuance of Debt
-CA$35.9k
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
MedMira Inc
XTSX:MIR
|
Net Issuance of Debt
CA$148.2k
|
CAGR 3-Years
-31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
Net Issuance of Debt
CA$23.7m
|
CAGR 3-Years
57%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Conavi Medical Corp
XTSX:CNVI
|
Net Issuance of Debt
-$1.6m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
StimCell Enegetics Inc
Glance View
StimCell Enegetics Inc is a CA-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2013-03-11. StimCell Enegetics Inc., formerly Cell MedX Corp., is a development stage electroceutical medical device company. The Company’s products include eBalance, and Bio Feedback. The eBalance is a non-invasive, fully automated microcurrent electrotherapy system administering pre-programmed algorithms. The biofeedback mechanism is where eBalance offering users and health professionals alike a real-time snapshot of cellular vitality. Its Microcurrent therapy uses molecular bioelectricity in cell-to-cell signaling. Microcurrent is a clinically tested therapy treatment used to treat a range of conditions. There is compelling research in diabetes care, wound therapy, migraine treatment, chronic obstructive pulmonary disease (COPD), and anti-ageing.
See Also
What is StimCell Enegetics Inc's Net Issuance of Debt?
Net Issuance of Debt
16k
USD
Based on the financial report for May 31, 2024, StimCell Enegetics Inc's Net Issuance of Debt amounts to 16k USD.
What is StimCell Enegetics Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
-44%
Over the last year, the Net Issuance of Debt growth was -95%. The average annual Net Issuance of Debt growth rates for StimCell Enegetics Inc have been -63% over the past three years , -44% over the past five years .
